Management of Severely Uncontrolled Diabetes: HbA1c 11.8% + RBS 512 mg/dL

Step 1 - Rule Out Acute Hyperglycemic Emergencies FIRST

• RBS 512 mg/dL with HbA1c 11.8% indicates severe, chronic, poorly controlled diabetes.
• If ketones positive or signs of DKA/HHS are present, admit and manage as an inpatient emergency (IV fluids, insulin infusion, electrolyte correction).
• If no ketoacidosis and the patient is clinically stable, outpatient/ambulatory intensification is appropriate.

Step 2 - Initial Assessment (Same Visit)

• Confirm type of diabetes: Type 1 vs Type 2 (C-peptide, anti-GAD antibodies if unclear)
• Baseline labs: CBC, RFT (eGFR, creatinine), LFT, lipid profile, urine ACR, TSH
• Complications screen: BP, foot exam, fundoscopy referral, urine microalbumin
• Identify precipitants: Infection, non-compliance, new medications (steroids), dietary indiscretion
• Current medications: What is the patient already on?

Step 3 - Glycemic Management (Core Decision)

"Insulin can be used as the initial therapy in severe hyperglycemia (blood glucose ≥300 mg/dL or HbA1c ≥10%)"

• Tintinalli's Emergency Medicine

"Patients with more severe hyperglycemia (FPG >250 mg/dL) may respond partially but are unlikely to achieve normoglycemia with oral therapy alone"

• Harrison's Principles of Internal Medicine, 22E

A. Insulin Regimen - Start Here

• Start Glargine or Detemir (basal insulin): 0.1-0.2 units/kg/day at bedtime
• Typical starting dose: 10 units at night (or 0.2 U/kg)
• Titrate by 2 units every 3 days targeting fasting glucose 80-130 mg/dL
• Continue metformin alongside unless contraindicated

• Long-acting insulin at night + Rapid-acting insulin (Aspart/Lispro) before meals
• Total daily dose: 0.3-0.5 units/kg/day, split 50% basal : 50% bolus

• 30/70 or 50/50 premix twice daily (before breakfast and dinner)
• Simpler but less flexible

Harrison's, 22E: "A single dose of long-acting insulin at bedtime is often effective in combination with metformin... as endogenous insulin production falls further, multiple injections of long-acting and rapid-acting insulin are necessary"

B. Oral/Injectable Agents - Combination Approach

Insulin (basal) + Metformin + GLP-1RA (or SGLT-2i if ASCVD/CKD present)

Step 4 - Monitoring Plan

• At HbA1c 11.8%, expect HbA1c to fall 2-3% over the first 3 months with proper insulin + oral agent combination.

Step 5 - Lifestyle + Education (Non-Negotiable)

• Medical nutrition therapy: Carbohydrate counting, low glycemic index diet, restrict refined sugars and processed foods
• Physical activity: 150 min/week moderate aerobic exercise (shown to reduce HbA1c significantly per meta-analysis, PMID 38887616)
• Weight loss: Even 5-10% weight reduction significantly improves insulin sensitivity
• Diabetes self-management education (DSME): Injection technique, glucose monitoring, hypoglycemia recognition
• Alcohol/smoking cessation

Step 6 - Intensification Milestones

Summary Decision Tree

RBS 512 + HbA1c 11.8%
        ↓
Check ketones + electrolytes
        ↓
Ketones (+) / altered mentation → Hospital: IV insulin + fluids (DKA/HHS protocol)
Ketones (-) / clinically stable  → Ambulatory intensification
        ↓
Assess comorbidities (ASCVD? CKD? Heart failure? Obesity?)
        ↓
Start Basal Insulin (10-20 U bedtime) + Metformin
        ↓
Add GLP-1RA (preferred) or SGLT-2i based on comorbidities
        ↓
Titrate every 3 days; reassess HbA1c at 3 months

• Harrison's Principles of Internal Medicine 22E (2025) - Type 2 DM Management
• Tintinalli's Emergency Medicine - Insulin indications for severe hyperglycemia
• Rosen's Emergency Medicine - Hyperglycemia management
• 2026 AACE T2D Algorithm, PMID 41842862 (note: erratum published, PMID 42283653)

Clinical note: The HbA1c 11.8% reflects average glucose of approximately 290 mg/dL over the past 3 months, confirming prolonged severe uncontrol. This patient almost certainly needs insulin at least in the short term, alongside oral agents and lifestyle changes.